Adams Chandra 4
4 · Surface Oncology, Inc. · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Adams Chandra
Deputy GC
Transactions
- Award
Stock Option (Right to Buy)
2023-03-01+50,000→ 50,000 totalExercise: $0.69Exp: 2033-03-01→ Common Stock (50,000 underlying) - Award
Stock Option (Right to Buy)
2023-03-01+50,000→ 50,000 totalExercise: $0.69Exp: 2033-03-01→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The Options shall vest in full on February 8, 2024, so long as the reporting person remains an employee or other service provider of the Issuer on such date.
- [F2]The Options shall vest in equal monthly installments over three years, so that all of the underlying shares shall be vested on February 8, 2026, so long as the reporting person remains an employee or other service provider of the Issuer on such dates.